Sign In
Buy UTHR
$549.47
+9.42 (+1.74%)
At Close: Jun 03, 2026
Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January
08:32am, Thursday, 25'th Jan 2024
From CRISPR gene editing to modify ideal agricultural traits, synthetic biology to promote eco-friendly engineering, or even that relating to biofuels, the field of biotechnology, also known as biotec
3 Must-Buy Healthcare Stocks for a Healthy 2024
05:27pm, Monday, 22'nd Jan 2024
Healthcare stocks remain a focal point for investors seeking stability and growth. The convergence of technology and an increased emphasis on global health has created an environment for ripe investme
Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market
03:57pm, Tuesday, 16'th Jan 2024
For many biotech stocks, price and performance hinges on the success of a drug in testing. This means most biotech companies rely on one market opportunity to succeed financially.
Here's Why United Therapeutics (UTHR) is a Strong Growth Stock
11:17am, Monday, 01'st Jan 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
United Therapeutics Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
06:00am, Friday, 29'th Dec 2023
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Dr. Martine Rothblatt, Chairperso
20 midcap stocks with 2024 upside ranging up to 62%, according to analysts
01:02pm, Tuesday, 26'th Dec 2023
When investors think about whether to increase their exposure beyond the big companies that grab most of the headlines in the financial media, they are likely to look at small-cap stocks first. After
United Therapeutics Corporation (UTHR) Q3 2023 Earnings Call Transcript
02:38pm, Wednesday, 01'st Nov 2023
United Therapeutics Corporation (NASDAQ:UTHR ) Q3 2023 Earnings Conference Call November 1, 2023 9:00 AM ET Company Participants Dewey Steadman – Head of Investor Relations Martine Rothblatt – Cha
United Therapeutics (UTHR) Q3 Earnings & Sales Beat Estimates
11:21am, Wednesday, 01'st Nov 2023
United Therapeutics (UTHR) third-quarter 2023 earnings and sales beat estimates. Tyvaso sales continue to drive the company's top line.
United Therapeutics (UTHR) Q3 Earnings and Revenues Top Estimates
08:16am, Wednesday, 01'st Nov 2023
United Therapeutics (UTHR) came out with quarterly earnings of $5.38 per share, beating the Zacks Consensus Estimate of $4.89 per share. This compares to earnings of $4.91 per share a year ago.
United Therapeutics Corporation to Present at the UBS Biopharma Conference 2023
06:00am, Tuesday, 31'st Oct 2023
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.,--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Patrick Poisson, Executive Vice
Miromatrix Medical climbs 225% following $140m United Therapeutics bid
08:21am, Monday, 30'th Oct 2023
Shares in the artificial human organs specialist Miromatrix Medical Inc. jumped 25% in premarket trading following the announcement of its acquisition by United Therapeutics Corporation (NASDAQ:UTHR)�
Miromatrix Medical stock soars after it agrees to be bought by United Therapeutics
06:23am, Monday, 30'th Oct 2023
Miromatrix Medical Inc.'s stock MIRO, -2.80% jumped 230% in premarket trades on Monday after the company agreed to be acquired by United Therapeutics Corp. UTHR, -2.30% for $3.25 per share in cash, or
United Therapeutics Corporation to Report Third Quarter 2023 Financial Results Before the Market Opens on Wednesday, November 1, 2023
06:00am, Wednesday, 25'th Oct 2023
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), announced today that it will report its third quarter 2023 financial results before
United Therapeutics: Both Fundamental And Technical Analyses Justify A Buy Decision
12:25pm, Sunday, 22'nd Oct 2023
United Therapeutics Corporation is in a long-term uptrend, reaching a new all-time high, indicating strong demand for the stock. The company has a competitive advantage with a diverse and unique produ
Bullet Proof Your Portfolio: 3 Must-Have Defensive Stocks for 2023
04:15pm, Wednesday, 20'th Sep 2023
Are you feeling the brunt of the market uncertainty in your retirement portfolio? Rebalancing your portfolio may be necessary at this stage.
